Product NDC: | 0054-0045 |
Proprietary Name: | Ipratropium Bromide |
Non Proprietary Name: | Ipratropium Bromide |
Active Ingredient(s): | 21 ug/1 & nbsp; Ipratropium Bromide |
Administration Route(s): | NASAL |
Dosage Form(s): | SPRAY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0054-0045 |
Labeler Name: | Roxane Laboratories, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076664 |
Marketing Category: | ANDA |
Start Marketing Date: | 20031105 |
Package NDC: | 0054-0045-44 |
Package Description: | 1 BOTTLE, SPRAY in 1 CARTON (0054-0045-44) > 345 SPRAY in 1 BOTTLE, SPRAY |
NDC Code | 0054-0045-44 |
Proprietary Name | Ipratropium Bromide |
Package Description | 1 BOTTLE, SPRAY in 1 CARTON (0054-0045-44) > 345 SPRAY in 1 BOTTLE, SPRAY |
Product NDC | 0054-0045 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ipratropium Bromide |
Dosage Form Name | SPRAY |
Route Name | NASAL |
Start Marketing Date | 20031105 |
Marketing Category Name | ANDA |
Labeler Name | Roxane Laboratories, Inc |
Substance Name | IPRATROPIUM BROMIDE |
Strength Number | 21 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |